![]() Cullgen Cullgen is a biotech drug discovery company dedicated to the development of targeted protein degraders. | ![]() AgomAb Therapeutics AgomAb Therapeutics is a biotherapeutics company developing molecular therapies for the regeneration of damaged tissues. | ||
Founding Date | Founding Date 2018 | Founding Date 2018 | Founding Date 2017 |
Type | Type Private | Type Private | Type Public |
Tags | |||
Locations | Locations Poitiers, FR HQ Chasseneuil Du Poitou, FR | Locations San Diego, US HQ Shanghai, CN Tokyo, JP | Locations Antwerpen, BE HQ Gent, BE |
Employees | Employees 833% increase | Employees 4 | Employees 62 |
Funding | |||
Latest funding round | Latest funding round $ 720.5k (over 6 years ago) | Latest funding round $ 16m (about 7 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 720.5k | Total funding raised $ 31m | Total funding raised $ 97.6m |

Cullgen is a biotech drug discovery company dedicated to the development of targeted protein degraders.
View company
AgomAb Therapeutics is a biotherapeutics company developing molecular therapies for the regeneration of damaged tissues.
View company